{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:21:09Z","timestamp":1792790469895,"version":"4.5.0"},"reference-count":155,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T00:00:00Z","timestamp":1560297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Adipose tissue has been recognized as a complex organ with endocrine and metabolic roles. The excess of fat mass, as occurs during overweight and obesity states, alters the regulation of adipose tissue, contributing to the development of obesity-related disorders. In this regard, many epidemiological studies shown an association between obesity and numerous types of malignancies, comprising those linked to the endocrine system (e.g., breast, endometrial, ovarian, thyroid and prostate cancers). Multiple factors may contribute to this phenomenon, such as hyperinsulinemia, dyslipidemia, oxidative stress, inflammation, abnormal adipokines secretion and metabolism. Among adipokines, growing interest has been placed in recent years on adiponectin (APN) and on its role in carcinogenesis. APN is secreted by adipose tissue and exerts both anti-inflammatory and anti-proliferative actions. It has been demonstrated that APN is drastically decreased in obese individuals and that it can play a crucial role in tumor growth. Although literature data on the impact of APN on carcinogenesis are sometimes conflicting, the most accredited hypothesis is that it has a protective action, preventing cancer development and progression. The aim of the present review is to summarize the currently available evidence on the involvement of APN and its signaling in the etiology of cancer, focusing on endocrine malignancies.<\/jats:p>","DOI":"10.3390\/ijms20122863","type":"journal-article","created":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T10:55:19Z","timestamp":1560336919000},"page":"2863","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":115,"title":["Adipose Tissue, Obesity and Adiponectin: Role in Endocrine Cancer Risk"],"prefix":"10.3390","volume":"20","author":[{"given":"Andrea","family":"Tumminia","sequence":"first","affiliation":[{"name":"Endocrinology, Department of Clinical and Experimental Medicine, University of Catania, Garibaldi Hospital, Via Palermo 636, 95122 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Vinciguerra","sequence":"additional","affiliation":[{"name":"Endocrinology, Department of Clinical and Experimental Medicine, University of Catania, Garibaldi Hospital, Via Palermo 636, 95122 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Parisi","sequence":"additional","affiliation":[{"name":"Endocrinology, Department of Clinical and Experimental Medicine, University of Catania, Garibaldi Hospital, Via Palermo 636, 95122 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Graziano","sequence":"additional","affiliation":[{"name":"Endocrinology, Department of Clinical and Experimental Medicine, University of Catania, Garibaldi Hospital, Via Palermo 636, 95122 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3258-7200","authenticated-orcid":false,"given":"Laura","family":"Sciacca","sequence":"additional","affiliation":[{"name":"Endocrinology, Department of Clinical and Experimental Medicine, University of Catania, Garibaldi Hospital, Via Palermo 636, 95122 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Baratta","sequence":"additional","affiliation":[{"name":"Endocrinology, Department of Clinical and Experimental Medicine, University of Catania, Garibaldi Hospital, Via Palermo 636, 95122 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7941-5828","authenticated-orcid":false,"given":"Lucia","family":"Frittitta","sequence":"additional","affiliation":[{"name":"Endocrinology, Department of Clinical and Experimental Medicine, University of Catania, Garibaldi Hospital, Via Palermo 636, 95122 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,6,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"NCD Risk Factor Collaboration (NCD-RisC) (2016). Trends in adult body-mass index in 200 countries from 1975 to 2014: A pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet, 387, 1377\u20131396.","DOI":"10.1016\/S0140-6736(16)30054-X"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration (BMI Mediated Effects), Lu, Y., Hajifathalian, K., Ezzati, M., Woodward, M., Rimm, E.B., and Danaei, G. (2014). Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: A pooled analysis of 97 prospective cohorts with 1.8 million participants. Lancet, 383, 970\u2013983.","DOI":"10.1016\/S0140-6736(13)61836-X"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-mass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/nrc3174","article-title":"Molecular mechanisms of cancer development in obesity","volume":"11","author":"Khandekar","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Global BMI Mortality Collaboration, Di Angelantonio, E., Bhupathiraju Sh, N., Wormser, D., Gao, P., Kaptoge, S., Berrington de Gonzalez, A., Cairns, B.J., Huxley, R., and Jackson Ch, L. (2016). Body-mass index and all-cause mortality: Individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet, 388, 776\u2013786.","DOI":"10.1016\/S0140-6736(16)30175-1"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.numecd.2013.05.006","article-title":"Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients","volume":"23","author":"Sciacca","year":"2013","journal-title":"Nutr. Metab. Cardiov. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s40618-016-0508-7","article-title":"Insulin, insulin receptors, and cancer","volume":"39","author":"Vigneri","year":"2016","journal-title":"J. Endocrinol. Invest."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.numecd.2005.10.013","article-title":"Obesity and cancer","volume":"16","author":"Vigneri","year":"2006","journal-title":"Nutr. Metab. Cardiov. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1515\/hmbci-2014-0037","article-title":"Adipose tissue, obesity and adipokines: Role in cancer promotion","volume":"21","author":"Booth","year":"2015","journal-title":"Hormone Mol. Biol. Clin. Invest."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.2337\/db16-0339","article-title":"The Multifaceted Roles of Adipose Tissue-Therapeutic Targets for Diabetes and Beyond: The 2015 Banting Lecture","volume":"65","author":"Scherer","year":"2016","journal-title":"Diabetes"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Di Zazzo, E., Polito, R., Bartollino, S., Nigro, E., Porcile, C., Bianco, A., Daniele, A., and Moncharmont, B. (2019). Adiponectin as Link Factor between Adipose Tissue and Cancer. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20040839"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1210\/jc.2003-031777","article-title":"Adiponectin relationship with lipid metabolism is independent of body fat mass: Evidence from both cross-sectional and intervention studies","volume":"89","author":"Baratta","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00592-013-0458-x","article-title":"Adiponectin increases glucose-induced insulin secretion through the activation of lipid oxidation","volume":"50","author":"Patane","year":"2013","journal-title":"Acta Diabetol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature01705","article-title":"Cloning of adiponectin receptors that mediate antidiabetic metabolic effects","volume":"423","author":"Yamauchi","year":"2003","journal-title":"Nature"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1158\/1078-0432.CCR-12-0930","article-title":"Molecular pathways: Adiponectin and leptin signaling in cancer","volume":"19","author":"Vansaun","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.20892\/j.issn.2095-3941.2015.0092","article-title":"Evolving role of adiponectin in cancer-controversies and update","volume":"13","author":"Katira","year":"2016","journal-title":"Cancer Biol. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2337\/dbi17-0016","article-title":"The Adiponectin Paradox for All-Cause and Cardiovascular Mortality","volume":"67","author":"Menzaghi","year":"2018","journal-title":"Diabetes"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"10302","DOI":"10.1073\/pnas.0403760101","article-title":"A family of Acrp30\/adiponectin structural and functional paralogs","volume":"101","author":"Wong","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1172\/JCI29709","article-title":"Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies","volume":"117","author":"Takemura","year":"2007","journal-title":"J. Clin. Invest."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.beem.2013.09.003","article-title":"Adiponectin receptors: A review of their structure, function and how they work","volume":"28","author":"Yamauchi","year":"2014","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"10308","DOI":"10.1073\/pnas.0403382101","article-title":"T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30\/adiponectin","volume":"101","author":"Hug","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.beem.2013.11.005","article-title":"Multifaceted roles of adiponectin in cancer","volume":"28","author":"Hebbard","year":"2014","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1210\/er.2011-1015","article-title":"The role of adiponectin in cancer: A review of current evidence","volume":"33","author":"Dalamaga","year":"2012","journal-title":"Endocr. Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.pharmthera.2013.01.008","article-title":"Adipocytes: Impact on tumor growth and potential sites for therapeutic intervention","volume":"138","author":"Scherer","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"451","DOI":"10.33549\/physiolres.931156","article-title":"Adiponectin as a potential marker of prostate cancer progression: Studies in organ-confined and locally advanced prostate cancer","volume":"57","author":"Housa","year":"2008","journal-title":"Physiol. Res."},{"key":"ref_26","first-page":"982769","article-title":"Serum adiponectin level and different kinds of cancer: A review of recent evidence","volume":"2012","author":"Izadi","year":"2012","journal-title":"ISRN Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1152\/physrev.00011.2008","article-title":"AMPK in Health and Disease","volume":"89","author":"Steinberg","year":"2009","journal-title":"Physiol. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc2676","article-title":"The LKB1-AMPK pathway: Metabolism and growth control in tumour suppression","volume":"9","author":"Shackelford","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1038\/onc.2009.129","article-title":"LKB1 is required for adiponectin-mediated modulation of AMPK-S6K axis and inhibition of migration and invasion of breast cancer cells","volume":"28","author":"Nagalingam","year":"2009","journal-title":"Oncogene"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1084\/jem.20181288","article-title":"Adiponectin accounts for gender differences in hepatocellular carcinoma incidence","volume":"216","author":"Manieri","year":"2019","journal-title":"J. Exp. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.tips.2004.12.011","article-title":"AMPK, the metabolic syndrome and cancer","volume":"26","author":"Luo","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_32","first-page":"80","article-title":"Mechanisms underlying the anti-proliferative actions of adiponectin in human breast cancer cells, MCF7-dependency on the cAMP\/protein kinase-A pathway","volume":"63","author":"Li","year":"2011","journal-title":"Nutr. Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1210\/jc.2006-1858","article-title":"Total and high-molecular-weight adiponectin in breast cancer: In vitro and in vivo studies","volume":"92","author":"Korner","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1158\/1940-6207.CAPR-08-0081","article-title":"The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase","volume":"1","author":"Zakikhani","year":"2008","journal-title":"Cancer Prev. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1677\/ERC-06-0091","article-title":"Adiponectin signals in prostate cancer cells through Akt to activate the mammalian target of rapamycin pathway","volume":"14","author":"Barb","year":"2007","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1677\/ERC-07-0065","article-title":"Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95 2","volume":"14","author":"Cong","year":"2007","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4161\/cam.1.3.4986","article-title":"The role of PP2A A subunits in tumor suppression","volume":"1","author":"Sablina","year":"2007","journal-title":"Cell Adhes. Migr."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.1158\/0008-5472.CAN-08-2641","article-title":"Adiponectin-activated AMPK stimulates dephosphorylation of AKT through protein phosphatase 2A activation","volume":"69","author":"Kim","year":"2009","journal-title":"Cancer Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1038\/sj.onc.1203527","article-title":"STATs in oncogenesis","volume":"19","author":"Bowman","year":"2000","journal-title":"Oncogene"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1210\/er.2010-0030","article-title":"Paracrine and endocrine effects of adipose tissue on cancer development and progression","volume":"32","author":"Park","year":"2011","journal-title":"Endocr. Rev."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1158\/0008-5472.CAN-09-2257","article-title":"Obesity and breast cancer: Progress to understanding the relationship","volume":"70","author":"Brown","year":"2010","journal-title":"Cancer Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.2174\/1381612823666170704122559","article-title":"Oncostatin M: Potential Implications for Malignancy and Metabolism","volume":"23","author":"Stephens","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrc2536","article-title":"Insulin and insulin-like growth factor signalling in neoplasia","volume":"8","author":"Pollak","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.numecd.2018.02.010","article-title":"Long-acting insulin analogs and cancer","volume":"28","author":"Sciacca","year":"2018","journal-title":"Nutr. Metab. Cardiov. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jcem.86.5.7463","article-title":"Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia","volume":"86","author":"Weyer","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/sj.bjc.6603051","article-title":"Adiponectin and cancer: A systematic review","volume":"94","author":"Kelesidis","year":"2006","journal-title":"Br. J. Cancer"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.molcel.2010.09.026","article-title":"Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress","volume":"40","author":"Sengupta","year":"2010","journal-title":"Mol. Cell"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nrc3677","article-title":"Lymphangiogenesis and lymphatic vessel remodelling in cancer","volume":"14","author":"Stacker","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3389\/fphys.2013.00275","article-title":"Adipose tissue immunity and cancer","volume":"4","author":"Catalan","year":"2013","journal-title":"Front. Physiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"R113","DOI":"10.1530\/JOE-14-0283","article-title":"The role of adipose tissue immune cells in obesity and low-grade inflammation","volume":"222","author":"Mraz","year":"2014","journal-title":"J. Endocrinol."},{"key":"ref_52","first-page":"637","article-title":"The Macrophage Switch in Obesity Development","volume":"6","author":"Castoldi","year":"2015","journal-title":"Front. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"658913","DOI":"10.1155\/2014\/658913","article-title":"New insight into adiponectin role in obesity and obesity-related diseases","volume":"2014","author":"Nigro","year":"2014","journal-title":"BioMed Res. Int."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Yanai, H., and Yoshida, H. (2019). Beneficial Effects of Adiponectin on Glucose and Lipid Metabolism and Atherosclerotic Progression: Mechanisms and Perspectives. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20051190"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1182\/blood.V96.5.1723","article-title":"Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages","volume":"96","author":"Yokota","year":"2000","journal-title":"Blood"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1073\/pnas.0308671100","article-title":"Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis","volume":"101","author":"Brakenhielm","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nrc2442","article-title":"Modes of resistance to anti-angiogenic therapy","volume":"8","author":"Bergers","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/cvr\/cvn034","article-title":"Adiponectin inhibits vascular endothelial growth factor-induced migration of human coronary artery endothelial cells","volume":"78","author":"Mahadev","year":"2008","journal-title":"Cardiov. Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1158\/0008-5472.CAN-07-2953","article-title":"T-cadherin supports angiogenesis and adiponectin association with the vasculature in a mouse mammary tumor model","volume":"68","author":"Hebbard","year":"2008","journal-title":"Cancer Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"Cancer J. Clin."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3322\/caac.21405","article-title":"Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention","volume":"67","author":"Friedman","year":"2017","journal-title":"Cancer J. Clin."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.mce.2013.09.030","article-title":"Clinical insights from adiponectin analysis in breast cancer patients reveal its anti-inflammatory properties in non-obese women","volume":"382","author":"Panis","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/mc.20764","article-title":"Influence of the metabolic syndrome on leptin and leptin receptor in breast cancer","volume":"50","author":"Carroll","year":"2011","journal-title":"Mol. Carcinog."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/BF02624625","article-title":"Growth of epithelium from a preneoplastic mammary outgrowth in response to mammary adipose tissue","volume":"25","author":"Beck","year":"1989","journal-title":"In Vitro Cell. Dev. Biol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"6408","DOI":"10.1038\/sj.onc.1206737","article-title":"Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization","volume":"22","author":"Iyengar","year":"2003","journal-title":"Oncogene"},{"key":"ref_67","first-page":"971","article-title":"Adiponectin mediates an antiproliferative response in human MDA-MB 231 breast cancer cells","volume":"20","author":"Benaitreau","year":"2008","journal-title":"Oncol. Rep."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-2007-956518","article-title":"Antiproliferative effect of adiponectin on MCF7 breast cancer cells: A potential hormonal link between obesity and cancer","volume":"39","author":"Arditi","year":"2007","journal-title":"Hormone Metab. Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.bbrc.2006.04.076","article-title":"Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells","volume":"345","author":"Dieudonne","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_70","first-page":"5699","article-title":"Association of serum adiponectin levels with breast cancer risk","volume":"9","author":"Miyoshi","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"ref_71","first-page":"1226","article-title":"Circulating adiponectin and breast cancer risk: A systematic review and meta-analysis","volume":"43","author":"Macis","year":"2014","journal-title":"In. J. Epidemiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1677\/ERC-06-0089","article-title":"Anthropometric measures, plasma adiponectin, and breast cancer risk","volume":"14","author":"Tian","year":"2007","journal-title":"Endocr. Cancer"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/CEJ.0b013e328364f293","article-title":"Circulating adiponectin levels and the risk of breast cancer: A meta-analysis","volume":"23","author":"Ye","year":"2014","journal-title":"Eur. J. Cancer Prev."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1210\/jc.2003-031804","article-title":"Adiponectin and breast cancer risk","volume":"89","author":"Mantzoros","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1210\/jc.2006-1975","article-title":"Plasma adiponectin concentrations and risk of incident breast cancer","volume":"92","author":"Tworoger","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s10549-008-9958-8","article-title":"The influence of overweight and insulin resistance on breast cancer risk and tumour stage at diagnosis: A prospective study","volume":"113","author":"Cust","year":"2009","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10549-009-0577-9","article-title":"Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients","volume":"119","author":"Hancke","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1200\/JCO.2011.35.2237","article-title":"Prognostic effect of circulating adiponectin in a randomized 2 x 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer","volume":"30","author":"Macis","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e11433","DOI":"10.1097\/MD.0000000000011433","article-title":"Serum adiponectin in breast cancer: A meta-analysis","volume":"97","author":"Gu","year":"2018","journal-title":"Medicine"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4048\/jbc.2011.14.2.96","article-title":"Expression of leptin, leptin receptor, adiponectin, and adiponectin receptor in ductal carcinoma in situ and invasive breast cancer","volume":"14","author":"Jeong","year":"2011","journal-title":"J. Breast Cancer"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e14359","DOI":"10.1097\/MD.0000000000014359","article-title":"Association of serum adiponectin with breast cancer: A meta-analysis of 27 case-control studies","volume":"98","author":"Yu","year":"2019","journal-title":"Medicine"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Liu, L.Y., Wang, M., Ma, Z.B., Yu, L.X., Zhang, Q., Gao, D.Z., Wang, F., and Yu, Z.G. (2013). The role of adiponectin in breast cancer: A meta-analysis. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0073183"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1753-4887.2011.00414.x","article-title":"Effect of diet on adiponectin levels in blood","volume":"69","author":"Silva","year":"2011","journal-title":"Nutr. Rev."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"16983","DOI":"10.1074\/jbc.M117.792838","article-title":"Insulin-like growth factor 1 signaling is essential for mitochondrial biogenesis and mitophagy in cancer cells","volume":"292","author":"Lyons","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"25823","DOI":"10.1074\/jbc.M100925200","article-title":"Insulin\/insulin-like growth factor-I and estrogen cooperate to stimulate cyclin E-Cdk2 activation and cell Cycle progression in MCF-7 breast cancer cells through differential regulation of cyclin E and p21(WAF1\/Cip1)","volume":"276","author":"Lai","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.1210\/jc.2003-030214","article-title":"Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: Cross-sectional and interventional studies","volume":"88","author":"Gavrila","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.breast.2016.07.025","article-title":"Serum resistin is inversely related to breast cancer risk in premenopausal women","volume":"29","author":"Georgiou","year":"2016","journal-title":"Breast"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Guo, M.M., Duan, X.N., Cui, S.D., Tian, F.G., Cao, X.C., Geng, C.Z., Fan, Z.M., Wang, X., Wang, S., and Jiang, H.C. (2015). Circulating High-Molecular-Weight (HMW) Adiponectin Level Is Related with Breast Cancer Risk Better than Total Adiponectin: A Case-Control Study. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0129246"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"11462","DOI":"10.1158\/0008-5472.CAN-06-1969","article-title":"Adiponectin modulates the glycogen synthase kinase-3beta\/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice","volume":"66","author":"Wang","year":"2006","journal-title":"Cancer Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/sj.bjc.6604166","article-title":"Effects of adiponectin on breast cancer cell growth and signaling","volume":"98","author":"Grossmann","year":"2008","journal-title":"Br. J. Cancer"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10549-007-9874-3","article-title":"Growth-inhibitory effect of adiponectin via adiponectin receptor 1 on human breast cancer cells through inhibition of S-phase entry without inducing apoptosis","volume":"112","author":"Nakayama","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"553","DOI":"10.4161\/cc.27455","article-title":"Evidences that estrogen receptor alpha interferes with adiponectin effects on breast cancer cell growth","volume":"13","author":"Mauro","year":"2014","journal-title":"Cell Cycle"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coph.2016.08.001","article-title":"Different molecular signaling sustaining adiponectin action in breast cancer","volume":"31","author":"Panno","year":"2016","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1096\/fj.201701315R","article-title":"Uncoupling effects of estrogen receptor alpha on LKB1\/AMPK interaction upon adiponectin exposure in breast cancer","volume":"32","author":"Mauro","year":"2018","journal-title":"FASEB J."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/BF02978210","article-title":"Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell","volume":"28","author":"Kang","year":"2005","journal-title":"Archives Pharm. Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.3892\/etm.2016.3251","article-title":"Circulating adiponectin levels and risk of endometrial cancer: Systematic review and meta-analysis","volume":"11","author":"Li","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e008541","DOI":"10.1136\/bmjopen-2015-008541","article-title":"Association between adiponectin levels and endometrial carcinoma risk: Evidence from a dose-response meta-analysis","volume":"5","author":"Lin","year":"2015","journal-title":"BMJ open"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1159\/000430327","article-title":"Adiponectin and Endometrial Cancer: A Systematic Review and Meta-Analysis","volume":"36","author":"Zeng","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Zheng, Q., Wu, H., and Cao, J. (2015). Circulating adiponectin and risk of endometrial cancer. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0129824"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/ijc.29561","article-title":"Circulating adiponectin, leptin and adiponectin-leptin ratio and endometrial cancer risk: Evidence from a meta-analysis of epidemiologic studies","volume":"137","author":"Gong","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"279","DOI":"10.5468\/ogs.2016.59.4.279","article-title":"Association of plasma adiponectin and leptin levels with the development and progression of ovarian cancer","volume":"59","author":"Jin","year":"2016","journal-title":"Obstetrics Gynecol. Sci."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/ijc.31172","article-title":"Adipokines and inflammation markers and risk of differentiated thyroid carcinoma: The EPIC study","volume":"142","author":"Dossus","year":"2018","journal-title":"Int. J. Cancer"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"4921803","DOI":"10.1155\/2018\/4921803","article-title":"Concentrations of Selected Adipokines, Interleukin-6, and Vitamin D in Patients with Papillary Thyroid Carcinoma in Respect to Thyroid Cancer Stages","volume":"2018","author":"Warakomski","year":"2018","journal-title":"Int. J. Endocrinol."},{"key":"ref_104","first-page":"3861","article-title":"Lack of Association between Serum Adiponectin\/Leptin Levels and Medullary Thyroid Cancer","volume":"17","author":"Abooshahab","year":"2016","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"E2023","DOI":"10.1210\/jc.2010-1908","article-title":"Circulating adiponectin is inversely associated with risk of thyroid cancer: In vivo and in vitro studies","volume":"96","author":"Mitsiades","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5301\/jbm.5000124","article-title":"The role of circulating adiponectin in prostate cancer: A meta-analysis","volume":"30","author":"Liao","year":"2015","journal-title":"Int. J. Biol. Markers"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.prnil.2015.07.001","article-title":"Serum adiponectin concentration in 2,939 Japanese men undergoing screening for prostate cancer","volume":"3","author":"Ikeda","year":"2015","journal-title":"Prostate Inte."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1373\/clinchem.2009.133272","article-title":"A 25-year prospective study of plasma adiponectin and leptin concentrations and prostate cancer risk and survival","volume":"56","author":"Li","year":"2010","journal-title":"Clin. Chem."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1158\/1055-9965.EPI-06-0082","article-title":"Obesity, adipokines, and prostate cancer in a prospective population-based study","volume":"15","author":"Baillargeon","year":"2006","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.urology.2004.12.053","article-title":"Prostate cancer and adiponectin","volume":"65","author":"Goktas","year":"2005","journal-title":"Urology"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"Cancer J. Clin."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/gyn.2015.0114","article-title":"The Impact of Obesity on Surgical Outcome in Endometrial Cancer Patients: A Systematic Review","volume":"32","author":"Orekoya","year":"2016","journal-title":"J. Gynecol. Surg."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1158\/1055-9965.EPI-10-0832","article-title":"Body mass index, hormone replacement therapy, and endometrial cancer risk: A meta-analysis","volume":"19","author":"Crosbie","year":"2010","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/ijo.2016.56","article-title":"Childhood body mass index and height and risk of histologic subtypes of endometrial cancer","volume":"40","author":"Aarestrup","year":"2016","journal-title":"Int. J. Obesity"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1158\/1055-9965.EPI-09-0372","article-title":"Obesity and cancer: The role of dysfunctional adipose tissue","volume":"18","author":"Visseren","year":"2009","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3802\/jgo.2013.24.4.336","article-title":"Serum leptin, adiponectin and endometrial cancer risk in Chinese women","volume":"24","author":"Ma","year":"2013","journal-title":"J. Gynecol. Oncol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ygyno.2015.02.012","article-title":"Adiponectin mediates antiproliferative and apoptotic responses in endometrial carcinoma by the AdipoRs\/AMPK pathway","volume":"137","author":"Zhang","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1210\/jc.2006-1371","article-title":"Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women","volume":"92","author":"Cust","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_119","first-page":"594","article-title":"Serum adiponectin in relation to endometrial cancer and endometrial hyperplasia with atypia in obese women","volume":"29","author":"Bedner","year":"2008","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1158\/1535-7163.MCT-11-0545","article-title":"Direct role of adiponectin and adiponectin receptors in endometrial cancer: In vitro and ex vivo studies in humans","volume":"10","author":"Moon","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3892\/ol.2014.1846","article-title":"Clinicopathological roles of adiponectin and leptin receptors in endometrial carcinoma","volume":"7","author":"Yabushita","year":"2014","journal-title":"Oncol. Lett."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1210\/en.2011-2123","article-title":"Minireview: Human ovarian cancer: Biology, current management, and paths to personalizing therapy","volume":"153","author":"Romero","year":"2012","journal-title":"Endocrinology"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"j4511","DOI":"10.1136\/bmj.j4511","article-title":"Obesity and gynaecological and obstetric conditions: Umbrella review of the literature","volume":"359","author":"Kalliala","year":"2017","journal-title":"BMJ"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ygyno.2013.02.006","article-title":"Obesity-associated adipokines correlate with survival in epithelial ovarian cancer","volume":"129","author":"Diaz","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5603\/EP.a2018.0081","article-title":"The role of adiponectin and leptin in the treatment of ovarian cancer patients","volume":"70","author":"Slomian","year":"2019","journal-title":"Endokr. Polska"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.12659\/MSM.899990","article-title":"Expression of Adiponectin Receptor-1 and Prognosis of Epithelial Ovarian Cancer Patients","volume":"23","author":"Li","year":"2017","journal-title":"Med. Sci. Monit."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12672-018-0331-z","article-title":"Adiponectin Reverses the Proliferative Effects of Estradiol and IGF-1 in Human Epithelial Ovarian Cancer Cells by Downregulating the Expression of Their Receptors","volume":"9","author":"Hoffmann","year":"2018","journal-title":"Hormones Cancer"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/obr.12321","article-title":"Adiposity and risk of thyroid cancer: A systematic review and meta-analysis","volume":"16","author":"Schmid","year":"2015","journal-title":"Obesity Rev."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1089\/thy.2013.0232","article-title":"Obesity and thyroid cancer: A clinical update","volume":"24","author":"Pappa","year":"2014","journal-title":"Thyroid"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s12013-012-9419-1","article-title":"Expression and biologic significance of adiponectin receptors in papillary thyroid carcinoma","volume":"65","author":"Cheng","year":"2013","journal-title":"Cell Biochem. Biophys."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Hu, M.B., Liu, S.H., Jiang, H.W., Bai, P.D., and Ding, Q. (2014). Obesity affects the biopsy-mediated detection of prostate cancer, particularly high-grade prostate cancer: A dose-response meta-analysis of 29,464 patients. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0106677"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s12032-013-0829-8","article-title":"Obesity has multifaceted impact on biochemical recurrence of prostate cancer: A dose-response meta-analysis of 36,927 patients","volume":"31","author":"Hu","year":"2014","journal-title":"Med. Oncol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"81049","DOI":"10.18632\/oncotarget.12747","article-title":"Genetic polymorphisms in leptin, adiponectin and their receptors affect risk and aggressiveness of prostate cancer: Evidence from a meta-analysis and pooled-review","volume":"7","author":"Hu","year":"2016","journal-title":"Oncotarget"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1158\/1055-9965.EPI-06-0621","article-title":"Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: A case control study","volume":"16","author":"Michalakis","year":"2007","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1002\/pros.23002","article-title":"Adiponectin as a potential tumor suppressor inhibiting epithelial-to-mesenchymal transition but frequently silenced in prostate cancer by promoter methylation","volume":"75","author":"Tan","year":"2015","journal-title":"Prostate"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/pcan.2011.53","article-title":"Adiponectin inhibits oxidative stress in human prostate carcinoma cells","volume":"15","author":"Lu","year":"2012","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.bbrc.2005.12.103","article-title":"Adiponectin as a growth inhibitor in prostate cancer cells","volume":"340","author":"Bub","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1007\/s13277-015-3067-1","article-title":"Adiponectin inhibits VEGF-A in prostate cancer cells","volume":"36","author":"Gao","year":"2015","journal-title":"Tumour Biol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1159\/000430313","article-title":"MiR-323 Inhibits Prostate Cancer Vascularization Through Adiponectin Receptor","volume":"36","author":"Gao","year":"2015","journal-title":"Cellular Physiol. Biochem."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/carcin\/bgv048","article-title":"Tumor expression of adiponectin receptor 2 and lethal prostate cancer","volume":"36","author":"Rider","year":"2015","journal-title":"Carcinogenesis"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1200\/JCO.2009.27.0793","article-title":"Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival","volume":"28","author":"Nguyen","year":"2010","journal-title":"J.Clin. Oncol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"32205","DOI":"10.18632\/oncotarget.4980","article-title":"A single nucleotide polymorphism in ADIPOQ predicts biochemical recurrence after radical prostatectomy in localized prostate cancer","volume":"6","author":"Gu","year":"2015","journal-title":"Oncotarget"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"358","DOI":"10.4161\/cam.4.3.11541","article-title":"Metastasis suppression by adiponectin: LKB1 rises up to the challenge","volume":"4","author":"Saxena","year":"2010","journal-title":"Cell Adhes. Migr."},{"key":"ref_145","first-page":"1488","article-title":"Acrp30 inhibits leptin-induced metastasis by downregulating the JAK\/STAT3 pathway via AMPK activation in aggressive SPEC-2 endometrial cancer cells","volume":"27","author":"Wu","year":"2012","journal-title":"Oncol. Rep."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2008.01.007","article-title":"Targeting AMPK: A new therapeutic opportunity in breast cancer","volume":"67","author":"Hadad","year":"2008","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Otvos, L., Haspinger, E., La Russa, F., Maspero, F., Graziano, P., Kovalszky, I., Lovas, S., Nama, K., Hoffmann, R., and Knappe, D. (2011). Design and development of a peptide-based adiponectin receptor agonist for cancer treatment. BMC Biotech., 11.","DOI":"10.1186\/1472-6750-11-90"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/bip.22627","article-title":"Optimization of adiponectin-derived peptides for inhibition of cancer cell growth and signaling","volume":"104","author":"Otvos","year":"2015","journal-title":"Biopolymers"},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Sun, Y., Zang, Z., Zhong, L., Wu, M., Su, Q., Gao, X., Zan, W., Lin, D., Zhao, Y., and Zhang, Z. (2013). Identification of adiponectin receptor agonist utilizing a fluorescence polarization based high throughput assay. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0063354"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.2337\/diabetes.50.9.2094","article-title":"PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein","volume":"50","author":"Maeda","year":"2001","journal-title":"Diabetes"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1023\/A:1024038127156","article-title":"Use of the peroxisome proliferator-activated receptor (PPAR) gamma ligand troglitazone as treatment for refractory breast cancer: A phase II study","volume":"79","author":"Burstein","year":"2003","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1517\/13543784.2015.971154","article-title":"Discontinued in 2013: Oncology drugs","volume":"24","author":"Williams","year":"2015","journal-title":"Exp. Opin. Invest. Drugs"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.3181\/0806-RM-192","article-title":"Adiponectin is a negative regulator of bone mineral and bone strength in growing mice","volume":"233","author":"Ealey","year":"2008","journal-title":"Exper. Biol. Med."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1126\/science.1249077","article-title":"Cell Biology. Ronning after the adiponectin receptors","volume":"342","author":"Holland","year":"2013","journal-title":"Science"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2337\/diacare.27.2.629","article-title":"Exercise increases adiponectin levels and insulin sensitivity in humans","volume":"27","author":"Kriketos","year":"2004","journal-title":"Diabetes Care"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/12\/2863\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:57:46Z","timestamp":1760187466000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/12\/2863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,12]]},"references-count":155,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,6]]}},"alternative-id":["ijms20122863"],"URL":"https:\/\/doi.org\/10.3390\/ijms20122863","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,12]]}}}